Serum Lipid and Lipoprotein Patterns in Patients With Liver Cirrhosis and Chronic Active Hepatitis
- 14 April 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (7) , 792-796
- https://doi.org/10.1001/archinte.1997.00440280120012
Abstract
Background: An impaired lipid metabolism is often found in patients with chronic liver diseases. Unfortunately, few studies are available concerning serum lipid and lipoprotein levels in patients with liver cirrhosis and chronic active hepatitis (CAH). Objectives: To evaluate low-density lipoprotein (LDL), high-density lipoprotein (HDL), very low-density lipoprotein (VLDL), and total cholesterol serum levels in patients with cirrhosis and CAH and control patients and to relate the findings to the severity of the cirrhosis (Child classification). Methods: We measured the serum lipid pattern in 34 consecutive patients with liver cirrhosis (15 men and 19 women; mean [±SD] age, 55±14 years; Child classes: 14 in A, 9 in B, 11 in C; patients with biliary cirrhosis were excluded), 34 patients with CAH, and 34 control patients. The 3 groups were matched for sex and age. Total serum, HDL cholesterol, and triglyceride levels were measured by enzymatic methods; serum LDL and VLDL levels were calculated. Results: In patients with cirrhosis, there was a significant decrease in LDL, HDL, and total cholesterol serum levels compared with both the patients with CAH and the control patients, while the VLDL cholesterol level in patients with cirrhosis was significantly lower compared with the control patients alone. A significant decrease in total cholesterol levels was also observed in the CAH group when compared with the control patients. In patients with cirrhosis, levels of LDL, HDL, and total serum cholesterol were progressively lower when comparing patients in Child class A with patients in class C. Conclusions: In this study, the striking decrease in the level of serum LDL cholesterol in patients with liver disease was related to the increasing severity of the disease. Accordingly, the assessment of the serum LDL cholesterol level is important for an effective treatment and prognostic evaluation of patients with chronic liver disease. Arch Intern Med. 1997;157:792-796This publication has 13 references indexed in Scilit:
- Lipoprotein metabolismReactome - a curated knowledgebase of biological pathways, 2006
- Chronic hepatitisPostgraduate Medicine, 2003
- Hepatic Clearance of Plasma Chylomicron RemnantsSeminars in Liver Disease, 1992
- Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolismJournal of Gastroenterology and Hepatology, 1992
- Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver diseaseJournal of Gastroenterology and Hepatology, 1992
- Superiority of the Child-Pugh Classification to Quantitative Liver Function Tests for Assessing Prognosis of Liver CirrhosisScandinavian Journal of Gastroenterology, 1989
- Plasma Lipoproteins and Apoproteins in Primary Biliary CirrhosisHepatology, 1985
- High-Density Lipoprotein Cholesterol and Liver DiseaseHepatology, 1983
- Plasma lipids and lipoproteins in liver disease.Gut, 1978
- Serum Lipids in InfectionNew England Journal of Medicine, 1969